197 related articles for article (PubMed ID: 8874974)
1. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center.
Rolston KV; Elting L; Waguespack S; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1996; 42(5):348-53. PubMed ID: 8874974
[TBL] [Abstract][Full Text] [Related]
2. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
Bodey GP; Ho DH; Elting L
Am J Med; 1988 Jul; 85(1A):49-51. PubMed ID: 3041819
[TBL] [Abstract][Full Text] [Related]
3. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Wang H; Chen MJ;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
[TBL] [Abstract][Full Text] [Related]
4. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Jones RN; Salazar JC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
[TBL] [Abstract][Full Text] [Related]
5. [The reliability of using impenem, meropenem, cefoperazone-sulbactam and piperacillin-tazobactam to treat nosocomial Gram-negative bacterial infections with Monte Carlo simulation].
Xiao YH; Hu YJ
Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):595-600. PubMed ID: 28789493
[No Abstract] [Full Text] [Related]
6. Comparative activity of newer antibiotics against gram-negative bacilli.
Knapp CC; Washington JA
Cleve Clin J Med; 1989; 56(2):161-6. PubMed ID: 2731335
[TBL] [Abstract][Full Text] [Related]
7. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Kouda M; Fukuhara J; Takeuchi M; Ohgawara M; Matsuzaki H; Tohi H; Furuhata N; Maruyama M; Sasaki K; Sawabe E; Ikeda A; Suzuki T; Satoh H; Takahashi I; Kimura F; Nomura H; Ono E
Jpn J Antibiot; 1998 Jul; 51(7):475-87. PubMed ID: 9755431
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility surveillance among gram-negative bacilli at a cancer center.
Jacobson K; Rolston K; Elting L; LeBlanc B; Whimbey E; Ho DH
Chemotherapy; 1999; 45(5):325-34. PubMed ID: 10473920
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Wang FD; Lin ML; Lee WS; Liu CY
Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
[TBL] [Abstract][Full Text] [Related]
11. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
Pendland SL; Messick CR; Jung R
Diagn Microbiol Infect Dis; 2002 Jan; 42(1):75-8. PubMed ID: 11821176
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antibacterial activity of cefoperazone-sulbactam].
Zhang Y; Zhang J; Zhou L
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America.
Sader HS; Carvalhaes CG; Streit JM; Castanheira M; Flamm RK
Int J Infect Dis; 2020 Feb; 91():32-37. PubMed ID: 31715325
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
[TBL] [Abstract][Full Text] [Related]
16. Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli.
Pohlman JK; Knapp CC; Ludwig MD; Washington JA
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):29-33. PubMed ID: 8950526
[TBL] [Abstract][Full Text] [Related]
17. [The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
Fujiue Y; Kuwabara M; Muroki K; Shimizu S; Watanabe Y; Awaya Y; Kodomari Y
Jpn J Antibiot; 1998 Jan; 51(1):26-36. PubMed ID: 9557274
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Kinoshita S; Kumagai S
Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282
[TBL] [Abstract][Full Text] [Related]
19. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
Verbist L; Glupczynski Y
Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
Kuo HY; Wang FD; Yen YF; Lin ML; Liu CY
New Microbiol; 2009 Jan; 32(1):49-55. PubMed ID: 19382669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]